Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints  L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis.
Susceptibility of Escherichia coli to the amoxycillin-clavulanate combination: which recommendations should be used to provide relevant information to.
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
L. Skjøt-Rasmussen, S. S. Olsen, L. Jakobsen, K. Ejrnæs, F. Scheutz, B
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Evidence of transmission of verocytotoxin-producing Escherichia coli O111 from a cattle stable to a child  E. Møller Nielsen, C. Jensen, D. Lau Baggesen 
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Quinolone resistance among Shigella spp
U.S. Jensen, J.D. Knudsen, S. Wehberg, D.B. Gregson, K.B. Laupland 
Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from Finland  M. Eklund, M. Bielaszewska, U.-M. Nakari,
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
L. Skjøt-Rasmussen, S. S. Olsen, L. Jakobsen, K. Ejrnæs, F. Scheutz, B
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Potential risk factors for infection with Candida spp
Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.
Clinical Microbiology and Infection
Escherichia coli native valve endocarditis
Tracking changes in the vraSR and graSR two component regulatory systems during the development and loss of vancomycin non-susceptibility in a clinical.
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
Vector control: a cornerstone in the malaria elimination campaign
Pharmacodynamics of doxycycline
Molecular mechanism of gentamicin resistance in Bartonella henselae
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
E.C. Böttger  Clinical Microbiology and Infection 
M.N. Al-Hasan, B.D. Lahr, J.E. Eckel-Passow, L.M. Baddour 
Laboratory diagnosis and biosafety issues of biological warfare agents
Elements of design: the knowledge on which we build
Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions  M. Sjölund, S. Bengtsson, J. Bonnedahl,
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000  T. Benfield, F. Espersen,
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Abstracts cont. Clinical Microbiology and Infection
Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis.
Pandemic lineages of extraintestinal pathogenic Escherichia coli
M. Sabaté, E. Moreno, T. Pérez, A. Andreu, G. Prats 
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Clinical infection services—the Leiden experience
C. Gagliotti, L. Nobilio, M.L. Moro 
Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain  L. Vinué, Y. Sáenz, S. Martínez,
An after-hours clinical liaison blood culture service—is it worth it?
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013  A. Badura, G. Feierl, G. Pregartner,
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting  A. Kronenberg, S. Koenig, S. Droz,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
G. Kahlmeter  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints  L. Jakobsen, D. Sandvang, V.F. Jensen, A.M. Seyfarth, N. Frimodt-Møller, A.M. Hammerum  Clinical Microbiology and Infection  Volume 13, Issue 8, Pages 830-832 (August 2007) DOI: 10.1111/j.1469-0691.2007.01751.x Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Distribution of gentamicin MICs for Escherichia coli isolates carrying aac(3)-II (n = 52), aac(3)-IV (n = 58) or ant(2″)-I (n = 10). Clinical Microbiology and Infection 2007 13, 830-832DOI: (10.1111/j.1469-0691.2007.01751.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions